Abstract:Background: Postnatal infection with cytomegalovirus (CMV) in verypreterm and very-low-birth-weight infants, transmitted through breast milk (BM), is potentially associated with adverse outcomes. This study aimed to investigate the incidence and clinical significance of postnatal CMV infection in a tertiary neonatal intensive care unit. Methods: Infants of CMV-seropositive mothers born in a neonatal intensive care unit in Melbourne, Australia, were observed for 14 weeks from birth in a prospective cohort study… Show more
“…One study did not report the birth weight of the infants studied [ 14 ]. Five studies reported outcomes for BPD diagnosed at postnatal age 28 days [ 13 , 14 , 17 , 28 , 31 ], and thirteen studies reported outcomes for BPD diagnosed at 36 weeks of postmenstrual age [ 12 , 14 – 16 , 18 , 20 , 28 – 34 ]. One study extracted data from a database using diagnostic codes only and did not account for diagnostic criteria for BPD [ 26 ].…”
Bronchopulmonary dysplasia (BPD) is the most common serious complication of very preterm infants (VPI) or very low birth weight (VLBW) infants. Studies implicate viral infections in etiopathogenesis. The aim of this study was to summarize the relationship between viral infections and BPD through a systematic review and meta-analysis. We searched PubMed, Embase, the Web of Science Core Collection, and the Cochrane Database on December 19, 2023. We included observational studies that examined the association between viral infections and BPD in preterm infants. We extracted data on study methods, participant characteristics, exposure assessment, and outcome measures. We assessed study risk of bias using the Newcastle-Ottawa Scale (NOS). We included 17 and 15 studies in the qualitative review and meta-analysis, respectively. The meta-analysis showed a significant association between viral infection and BPD diagnosed at 36 weeks postmenstrual age (odds ratio (OR): 2.42, 95% confidence interval: 1.89–3.09, 13 studies, very low certainty of evidence). In a subgroup analysis of specific viruses, cytomegalovirus (CMV) proved to be significantly associated with BPD diagnosed at 36 weeks postmenstrual age (OR: 2.34, 95% confidence interval: 1.80–3.05, 11 studies). We did not find an association between viral infection and BPD diagnosed on the 28th day of life, probably due to the small sample size of the included prospective studies. Conclusion: Viral infections, especially CMV, are associated with an increased risk of BPD in preterm infants. Methodologically reliable prospective studies with large samples are needed to validate our conclusions, and high-quality randomized controlled studies are needed to explore the effect of prevention or treatment of viral infections on the incidence of BPD.
What is Known:• Studies have attempted to identify viral infections and bronchopulmonary dysplasia in preterm infants; however, results have been inconsistent.
What is New:• Systematic demonstration that viral infections, particularly cytomegalovirus, are positively associated with bronchopulmonary dysplasia diagnosed in preterm infants at the 36th week of postmenstrual age.• The importance of screening for viral infections in preterm infants, especially cytomegalovirus. More high-quality studies should be produced in the future to investigate the causal relationship between viral infections and bronchopulmonary dysplasia.
“…One study did not report the birth weight of the infants studied [ 14 ]. Five studies reported outcomes for BPD diagnosed at postnatal age 28 days [ 13 , 14 , 17 , 28 , 31 ], and thirteen studies reported outcomes for BPD diagnosed at 36 weeks of postmenstrual age [ 12 , 14 – 16 , 18 , 20 , 28 – 34 ]. One study extracted data from a database using diagnostic codes only and did not account for diagnostic criteria for BPD [ 26 ].…”
Bronchopulmonary dysplasia (BPD) is the most common serious complication of very preterm infants (VPI) or very low birth weight (VLBW) infants. Studies implicate viral infections in etiopathogenesis. The aim of this study was to summarize the relationship between viral infections and BPD through a systematic review and meta-analysis. We searched PubMed, Embase, the Web of Science Core Collection, and the Cochrane Database on December 19, 2023. We included observational studies that examined the association between viral infections and BPD in preterm infants. We extracted data on study methods, participant characteristics, exposure assessment, and outcome measures. We assessed study risk of bias using the Newcastle-Ottawa Scale (NOS). We included 17 and 15 studies in the qualitative review and meta-analysis, respectively. The meta-analysis showed a significant association between viral infection and BPD diagnosed at 36 weeks postmenstrual age (odds ratio (OR): 2.42, 95% confidence interval: 1.89–3.09, 13 studies, very low certainty of evidence). In a subgroup analysis of specific viruses, cytomegalovirus (CMV) proved to be significantly associated with BPD diagnosed at 36 weeks postmenstrual age (OR: 2.34, 95% confidence interval: 1.80–3.05, 11 studies). We did not find an association between viral infection and BPD diagnosed on the 28th day of life, probably due to the small sample size of the included prospective studies. Conclusion: Viral infections, especially CMV, are associated with an increased risk of BPD in preterm infants. Methodologically reliable prospective studies with large samples are needed to validate our conclusions, and high-quality randomized controlled studies are needed to explore the effect of prevention or treatment of viral infections on the incidence of BPD.
What is Known:• Studies have attempted to identify viral infections and bronchopulmonary dysplasia in preterm infants; however, results have been inconsistent.
What is New:• Systematic demonstration that viral infections, particularly cytomegalovirus, are positively associated with bronchopulmonary dysplasia diagnosed in preterm infants at the 36th week of postmenstrual age.• The importance of screening for viral infections in preterm infants, especially cytomegalovirus. More high-quality studies should be produced in the future to investigate the causal relationship between viral infections and bronchopulmonary dysplasia.
“…Notably, a study involving very low birth weight neonates in intensive care units found that postnatal CMV infection through breast milk significantly increased the risk of mortality and bronchopulmonary dysplasia [17]. However, long-term consequences of CMV infection transmitted through contaminated breast milk have not been reported [24]. A recent study by Midgley et al (2020) has reported that, compared to formula feeding and caesarean section, breastfeeding and vaginal delivery respectively increase the likelihood of postnatal CMV infection (OR=3.801, 95% CI: 2.474-5.840, p<0.001; OR=1.818, 95% CI: 1.190-2.196, p<0.001) [25].…”
Cytomegalovirus (CMV) infection poses significant health risks, particularly for vulnerable populations including fetuses infected in utero, premature infants, and immunocompromised individuals. CMV infection is the most prevalent cause of congenital infection, affecting approximately 0.5% to 2% of all live births worldwide. Congenital transmission during pregnancy is a major concern, with a variety of fetal and neonatal outcomes ranging from asymptomatic infection to severe abnormalities, including sensorineural hearing loss, visual impairment, various neurological sequelae, growth retardation and potentially fatal consequences. Congenital transmission of CMV from mother to fetus can occur through primary infection, or reactivation of a previous infection. Diagnosis involves imaging techniques and invasive procedures to detect CMV DNA. Antiviral medications have limited data for use during pregnancy, while ganciclovir or valganciclovir demonstrates potential benefits in neonates with symptomatic disease. Routine antenatal screening is not yet recommended, but serological testing may be warranted in specific circumstances. Preventive measures focus on simple hygiene practices. Childbirth and breastfeeding present potential risks of CMV transmission, highlighting the importance of close monitoring and informed decision-making. This narrative review aims to provide a comprehensive summary of the epidemiology, transmission patterns, clinical manifestations, diagnostic approaches, treatment modalities, screening methods, preventive measures, and breastfeeding considerations related to CMV infection. This knowledge is essential for healthcare professionals to effectively manage CMV infection and improve outcomes for affected individuals and their families.
“…Risk factors for infant symptomatic infection include VLBW, gestational age < 32 weeks, and level of DNA lactia [77••]. Three systematic reviews [78][79][80] published regarding CMV transmission via untreated or fresh breast milk found a rate of transmission to infants between 19 and 25%.…”
Section: Postnatal Cytomegalovirus Infection Prevalence and Presentat...mentioning
Purpose of review
There have been recent advances in the field of congenital CMV infection (cCMV) related to antiviral treatment of pregnant women and infants, the implementation of newborn CMV screening programs, and the frequency and diagnosis of complications among infected children. In addition, postnatal CMV infection (pCMV) is increasingly recognized as a potential cause of long-term sequelae in addition to acute complications among preterm infants, raising important questions related to treatment, and prevention.
Recent findings
High-dose valacyclovir appears to be safe and effective for the prevention of cCMV among women with first-trimester primary CMV infection. New studies reveal high rates of vestibular dysfunction and neuropsychiatric manifestations among children with cCMV. Some studies report associations between pCMV and long-term consequences, including neurodevelopmental delay and bronchopulmonary dysplasia, among very low birth weight infants, in addition to high risk of sepsis and death acutely, which has motivated efforts to eliminate the virus from breast milk by different methods.
Summary
More long-term complications of cCMV are increasingly recognized among children previously thought to be asymptomatic. Although a preventive CMV vaccine may be achievable, strategies to reduce the burden of cCMV disease include maternal education about risk-reduction behaviors, antiviral treatment of pregnant women with primary infection, and newborn screening to allow timely, appropriate care. Similarly, although it remains unclear if pCMV causes long-term problems, there is growing interest in identifying and preventing disease from CMV infections among preterm infants.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.